To amend title XIX of the Social Security Act to provide for public disclosure of average manufacturer prices (AMP) and best prices for prescription drugs.
Prescription Drug Pricing and Medicaid Fraud Prevention Act of 2005 - Amends title XIX (Medicaid) of the Social Security Act to require the Secretary of Health and Human Services to disclose publicly the average manufacturer prices (AMP) and best prices for prescription drugs.
Requires each drug manufacturer with a rebate agreement in effect to report to the Secretary detailed information (specified by the Secretary) on how the AMP is computed, including assumptions used.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line